Collegium Pharmaceutical (NASDAQ:COLL) Cut to "Hold" at StockNews.com
StockNews.com downgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) from a buy rating to a hold rating in a research note released on Tuesday morning. Other equities research analysts also recently issued research reports about the stock. Piper Sandler reduced their price objective on shares of Collegium Pharmaceutical from $37.00 to $35.00 in a […]